Exact Mass: 319.0524

Exact Mass Matches: 319.0524

Found 37 metabolites which its exact mass value is equals to given mass value 319.0524, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

6-Hydroxydelphinidin

3,5,6,7-Tetrahydroxy-2-(3,4,5-trihydroxyphenyl)-flavylium

C15H11O8 (319.0454)


   
   
   
   

2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide

2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide

C14H13N3O2S2 (319.0449)


   

Hernandonine

Hernandonine

C18H9NO5 (319.0481)


An oxoaporphine alkaloid isolated from Hernandia ovigera and Lindera chunii and has been shown exhibit inhibitory activity against HIV-1 integrase .

   

Cassameridine

Cassameridine

C18H9NO5 (319.0481)


An oxoaporphine alkaloid that is 7H-dibenzo[de,g]quinolin-7-one which is substituted by methylenedioxy grups at the 1,2 and 9,10 positions. Compared with liriodenine, which lacks the 9,10-methylenedioxy group, cassameridine displays only moderate antifungal activity.

   
   

3-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]benzoic acid

3-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]benzoic acid

C16H14ClNO4 (319.0611)


   

1-(3-Bromo-5-methylpyridin-2-yl)-4-ethylpiperazine hydrochloride

1-(3-Bromo-5-methylpyridin-2-yl)-4-ethylpiperazine hydrochloride

C12H19BrClN3 (319.0451)


   

6,7-Difluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid

6,7-Difluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid

C16H8F3NO3 (319.0456)


   

4-(4-chloro-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one

4-(4-chloro-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one

C15H11ClFN3O2 (319.0524)


   
   

Diphenylammonium trifluoromethanesulfonate

Diphenylammonium trifluoromethanesulfonate

C13H12F3NO3S (319.049)


   

Neodymium tri(2-propanolate)

Neodymium tri(2-propanolate)

C9H21NdO3 (319.0568)


   

5-BROMO-3-(2-PYRIDIN-2-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

5-BROMO-3-(2-PYRIDIN-2-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

C13H14BrN5 (319.0433)


   

5-BROMO-3-(2-PYRIDIN-3-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

5-BROMO-3-(2-PYRIDIN-3-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

C13H14BrN5 (319.0433)


   

3-FLUORO-5-(5-((2-METHYLTHIAZOL-4-YL)ETHYNYL)PYRIDIN-2-YL)BENZONITRILE

3-FLUORO-5-(5-((2-METHYLTHIAZOL-4-YL)ETHYNYL)PYRIDIN-2-YL)BENZONITRILE

C18H10FN3S (319.0579)


   

5-[3,5-Bis(trifluoromethyl)phenyl]-3-pyridinecarbaldehyde

5-[3,5-Bis(trifluoromethyl)phenyl]-3-pyridinecarbaldehyde

C14H7F6NO (319.0432)


   

TRANS-3-CHLORO-4-BENZYLOXY-5-METHOXY-BE&

TRANS-3-CHLORO-4-BENZYLOXY-5-METHOXY-BE&

C16H14ClNO4 (319.0611)


   

TRANS-2-CHLORO-3-BENZYLOXY-4-METHOXY-BE&

TRANS-2-CHLORO-3-BENZYLOXY-4-METHOXY-BE&

C16H14ClNO4 (319.0611)


   

4-(3-Chloro-2-fluoroanilino)-6-hydroxy-7- methoxyquinazoline

4-(3-Chloro-2-fluoroanilino)-6-hydroxy-7- methoxyquinazoline

C15H11ClFN3O2 (319.0524)


   

OCTYL RESIN

OCTYL RESIN

C13H9N3O7 (319.044)


   

N-Cbz-S-2-Chlorophenylglycine

N-Cbz-S-2-Chlorophenylglycine

C16H14ClNO4 (319.0611)


   

FAAH-IN-2

4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol

C15H11ClFN3O2 (319.0524)


FAAH-IN-2 (O-Desmorpholinopropyl Gefitinib) is a potent FAAH(fatty acid amide hydrolase) inhibitor extracted from Patent WO/2008/100977A2.

   

tert-Butyl 5-chloro-6-(trifluoromethyl)-1H-indole-1-carboxylate

tert-Butyl 5-chloro-6-(trifluoromethyl)-1H-indole-1-carboxylate

C14H13ClF3NO2 (319.0587)


   

2-Acetylaminofluorene-N-sulfate

2-Acetylaminofluorene-N-sulfate

C15H13NO5S (319.0514)


   

2-Hydroxy-4-methylbenzoic acid [2-(2-chloroanilino)-2-oxoethyl] ester

2-Hydroxy-4-methylbenzoic acid [2-(2-chloroanilino)-2-oxoethyl] ester

C16H14ClNO4 (319.0611)


   

N-(4-methyl-2-thiazolyl)-3-(2-oxo-1,3-benzothiazol-3-yl)propanamide

N-(4-methyl-2-thiazolyl)-3-(2-oxo-1,3-benzothiazol-3-yl)propanamide

C14H13N3O2S2 (319.0449)


   

5-Methyldeoxycytidine 5-phosphate

5-Methyldeoxycytidine 5-phosphate

C10H14N3O7P-2 (319.0569)


   

(2R,3R)-3,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-2,3-dihydrochromen-5-olate

(2R,3R)-3,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-2,3-dihydrochromen-5-olate

C15H11O8- (319.0454)


   

N-[4-[[acetamido(sulfanylidene)methyl]amino]phenyl]-2-thiophenecarboxamide

N-[4-[[acetamido(sulfanylidene)methyl]amino]phenyl]-2-thiophenecarboxamide

C14H13N3O2S2 (319.0449)


   

6-Ethoxy-2-[(4-fluorophenyl)methylthio]-1,3-benzothiazole

6-Ethoxy-2-[(4-fluorophenyl)methylthio]-1,3-benzothiazole

C16H14FNOS2 (319.0501)


   

3-[[(3-Chloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid

3-[[(3-Chloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid

C16H14ClNO4 (319.0611)


   

N-(1-cyano-3-pyrrolidinyl)-4-(trifluoromethyl)benzenesulfonamide

N-(1-cyano-3-pyrrolidinyl)-4-(trifluoromethyl)benzenesulfonamide

C12H12F3N3O2S (319.0602)


   

(2S)-2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide

(2S)-2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide

C14H13N3O2S2 (319.0449)


   

5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(22),2,4(8),9,12(23),13,15,17-octaen-11-one

5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(22),2,4(8),9,12(23),13,15,17-octaen-11-one

C18H9NO5 (319.0481)